finding,pubmed_id,finding_id
"The study demonstrated the efficacy of a fixed-dose combination of 400 mg paracetamol, 4.0 mg chlorphenamine, and 4.0 mg phenylephrine in reducing flu-like symptoms by both objective evaluation of symptoms by the investigators and subjective reports provided by patients themselves.",PMC4222817,PMC4222817_0
The evaluation of patient-reported symptom scores (study diary) by anova showed a statistically significant reduction in symptom scores in the treatment group as compared with the placebo groups (p ≤ 0.05).,PMC4222817,PMC4222817_1
"Analysis of the incidence of specific symptoms in each group did not reveal any statistically significant differences, and the distribution of the number of adverse events was homogeneous in the two groups.",PMC4222817,PMC4222817_2
"The time to freedom from symptoms was lower in the treatment group than in the placebo group, although the difference did not reach statistical significance.",PMC4222817,PMC4222817_3
The comparison of baseline and final scores revealed a statistically significant reduction in symptom scores in the treatment group as compared with the placebo groups (p ≤ 0.05).,PMC4222817,PMC4222817_4
The comparison of mean heart rate (hr) variation before and after treatment did not reveal any statistically significant between-group differences (p = 0.11).,PMC4222817,PMC4222817_5
The comparison of mean systolic blood pressure (sbp) variation attributable to treatment did not reveal any statistically significant between-group differences (p = 0.092).,PMC4222817,PMC4222817_6
The study drug reduced the frequency of use of rescue medication as compared with the placebo group (p = 0.002).,PMC4222817,PMC4222817_7
The study drug reduced the rate of symptom resolution as compared with the placebo group (p = 0.015).,PMC4222817,PMC4222817_8
